China National Medicines Corp Ltd (600511) — Net Asset Quality Index
China National Medicines Corp Ltd (600511) has a Net Asset Quality Index of 56.7% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥35.13 Billion minus total liabilities of CN¥15.19 Billion yields net assets of CN¥19.93 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check 600511 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
China National Medicines Corp Ltd Net Asset Quality Index Over Time (1999–2024)
This chart shows how China National Medicines Corp Ltd's Net Asset Quality Index has evolved across 26 annual periods from 1999 to 2024. As of September 2025, the index stands at 56.7%, representing net assets of CN¥19.93 Billion against total assets of CN¥35.13 Billion CNY. See 600511 working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for China National Medicines Corp Ltd (1999–2024)
The table below presents the year-by-year Net Asset Quality Index for China National Medicines Corp Ltd from 1999 to 2024, covering 26 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see market cap of China National Medicines Corp Ltd.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 54.3% | CN¥18.98 Billion | CN¥34.93 Billion | CN¥15.95 Billion | ▲ +0.3 pp |
| 2023 | 54.0% | CN¥17.53 Billion | CN¥32.45 Billion | CN¥14.92 Billion | ▲ +0.5 pp |
| 2022 | 53.6% | CN¥15.86 Billion | CN¥29.61 Billion | CN¥13.75 Billion | ▲ +1.3 pp |
| 2021 | 52.2% | CN¥14.36 Billion | CN¥27.48 Billion | CN¥13.12 Billion | ▼ -0.3 pp |
| 2020 | 52.6% | CN¥13.09 Billion | CN¥24.90 Billion | CN¥11.81 Billion | ▲ +2.3 pp |
| 2019 | 50.3% | CN¥12.16 Billion | CN¥24.19 Billion | CN¥12.03 Billion | ▲ +0.9 pp |
| 2018 | 49.3% | CN¥10.61 Billion | CN¥21.51 Billion | CN¥10.90 Billion | ▲ +2.4 pp |
| 2017 | 46.9% | CN¥9.46 Billion | CN¥20.17 Billion | CN¥10.71 Billion | ▼ -7.4 pp |
| 2016 | 54.3% | CN¥4.02 Billion | CN¥7.40 Billion | CN¥3.38 Billion | ▲ +0.7 pp |
| 2015 | 53.6% | CN¥3.51 Billion | CN¥6.56 Billion | CN¥3.04 Billion | ▲ +7.0 pp |
| 2014 | 46.6% | CN¥2.58 Billion | CN¥5.54 Billion | CN¥2.96 Billion | ▲ +3.4 pp |
| 2013 | 43.2% | CN¥2.20 Billion | CN¥5.08 Billion | CN¥2.88 Billion | ▲ +2.2 pp |
| 2012 | 41.0% | CN¥1.87 Billion | CN¥4.56 Billion | CN¥2.69 Billion | ▼ -2.2 pp |
| 2011 | 43.2% | CN¥1.53 Billion | CN¥3.55 Billion | CN¥2.02 Billion | ▲ +3.6 pp |
| 2010 | 39.6% | CN¥1.34 Billion | CN¥3.39 Billion | CN¥2.05 Billion | ▲ +0.6 pp |
| 2009 | 39.0% | CN¥1.08 Billion | CN¥2.78 Billion | CN¥1.69 Billion | ▼ -4.5 pp |
| 2008 | 43.5% | CN¥868.25 Million | CN¥2.00 Billion | CN¥1.13 Billion | ▲ +6.4 pp |
| 2007 | 37.1% | CN¥725.96 Million | CN¥1.96 Billion | CN¥1.23 Billion | ▼ -6.3 pp |
| 2006 | 43.4% | CN¥590.99 Million | CN¥1.36 Billion | CN¥771.05 Million | ▲ +2.7 pp |
| 2005 | 40.7% | CN¥521.33 Million | CN¥1.28 Billion | CN¥759.27 Million | ▼ -0.2 pp |
| 2004 | 40.9% | CN¥488.38 Million | CN¥1.19 Billion | CN¥704.48 Million | ▼ -2.1 pp |
| 2003 | 43.1% | CN¥468.65 Million | CN¥1.09 Billion | CN¥619.80 Million | ▼ -6.4 pp |
| 2002 | 49.4% | CN¥399.62 Million | CN¥808.37 Million | CN¥408.75 Million | ▲ +18.5 pp |
| 2001 | 30.9% | CN¥134.77 Million | CN¥435.76 Million | CN¥300.99 Million | ▼ -1.6 pp |
| 2000 | 32.5% | CN¥124.50 Million | CN¥382.83 Million | CN¥258.33 Million | ▲ +11.1 pp |
| 1999 | 21.4% | CN¥122.05 Million | CN¥570.85 Million | CN¥448.80 Million | — |